Pathogenesis and Management of Adult-Onset Still's Disease

Seminars in Arthritis and Rheumatism

Volumn 36, Issue 3, 2006, Pages 144-152

  Efthimiou, Petros ^a   Georgy, Sharon ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

adult Still's disease; adult onset Still's disease; AOSD; biologic agents; quotidian fever

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE ANTIBODY; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 6 ANTIBODY; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT ONSET STILL DISEASE; AMYLOIDOSIS; ARTHRITIS; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEVER; HUMAN; INFECTION; INFLAMMATION; INFORMATION RETRIEVAL; LOW DRUG DOSE; MEDICAL LITERATURE; MEDLINE; MONOTHERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RARE DISEASE; RASH; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; STILL'S DISEASE, ADULT-ONSET;

EID: 33750616012     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2006.07.001     Document Type: Article

References (86)

1. Efthimiou P., Paik P.K., and Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65 5 (2006) 564-572
2. Bywaters E.G. Still's disease in the adult. Ann Rheum Dis 30 2 (1971) 121-133
3. Bannatyne G.A., and Wohlmann A.S. Rheumatoid Arthritis: its clinical history, etiology and pathology. Lancet 1 (1896) 1120-1125
4. van de Putte L.B., and Wouters J.M. Adult-onset Still's disease. Baillieres Clin Rheumatol 5 2 (1991) 263-275
5. Ohta A., Yamaguchi M., Kaneoka H., Nagayoshi T., and Hiida M. Adult Still's disease: review of 228 cases from the literature. J Rheumatol 14 6 (1987) 1139-1146
6. Pouchot J., Sampalis J.S., Beaudet F., Carette S., Decary F., Salusinsky-Sternbach M., et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70 2 (1991) 118-136
7. Kadar J., and Petrovicz E. Adult-onset Still's disease. Best Pract Res Clin Rheumatol 18 5 (2004) 663-676
8. Ohta A., Yamaguchi M., Tsunematsu T., Kasukawa R., Mizushima H., Kashiwagi H., et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 17 8 (1990) 1058-1063 1990.
9. Escudero F.J., Len O., Falco V., de Sevilla T.F., and Sellas A. Rubella infection in adult onset Still's disease. Ann Rheum Dis 59 6 (2000) 493
10. Perez C., and Artola V. Adult Still's disease associated with Mycoplasma pneumoniae infection. Clin Infect Dis 32 6 (2001) E105-E106
11. Wouters J.M., Reekers P., and van de Putte L.B. Adult-onset Still's disease. Disease course and HLA associations. Arthritis Rheum 29 3 (1986) 415-418
12. Terkeltaub R., Esdaile J.M., Decary F., Harth M., Lister J., and Lapointe N. HLA-Bw35 and prognosis in adult Still's disease. Arthritis Rheum 24 12 (1981) 1469-1472
13. Miller M.L., Aaron S., Jackson J., Fraser P., Cairns L., Hoch S., et al. HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 28 2 (1985) 146-150
14. Fujii T., Nojima T., Yasuoka H., Satoh S., Nakamura K., Kuwana M., et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) 40 12 (2001) 1398-1404
15. Joung C.I., Lee H.S., Lee S.W., Kim C.G., Song Y.H., Jun J.B., et al. Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea. Clin Exp Rheumatol 21 4 (2003) 489-492
16. Hoshino T., Ohta A., Yang D., Kawamoto M., Kikuchi M., Inoue Y., et al. Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol 25 2 (1998) 396-398
17. Chen D.Y., Lan J.L., Lin F.J., Hsieh T.Y., and Wen M.C. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 63 10 (2004) 1300-1306
18. de Benedetti F., and Martini A. Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?. [comment]. Arthritis Rheum 52 3 (2005) 687-693
19. Matsui K., Tsuchida T., Hiroishi K., Tominaga K., Hayashi N., Hada T., et al. High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease. Rheumatology (Oxford) 38 5 (1999) 477-478
20. Kawashima M., Yamamura M., Taniai M., Yamauchi H., Tanimoto T., Kurimoto M., et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 44 3 (2001) 550-560
21. Sugiura T., Kawaguchi Y., Harigai M., Terajima-Ichida H., Kitamura Y., Furuya T., et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 3 7 (2002) 394-399
22. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 6552 (1995) 88-91
23. Esdaile J.M., Tannenbaum H., Lough J., and Hawkins D. Hepatic abnormalities in adult onset Still's disease. J Rheumatol 6 6 (1979) 673-679
24. Tsutsui H., Matsui K., Okamura H., and Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 174 (2000) 192-209
25. Sakao Y., Takeda K., Tsutsui H., Kaisho T., Nomura F., Okamura H., et al. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol 11 3 (1999) 471-480
26. Maeno N., Takei S., Imanaka H., Yamamoto K., Kuriwaki K., Kawano Y., et al. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. Arthritis Rheum 50 6 (2004) 1935-1938
27. Chen D.Y., Lan J.L., Lin F.J., and Hsieh T.Y. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 31 11 (2004) 2189-2198
28. Ogata A., Kitano M., Yamanaka J., Yamasaki T., Hashimoto N., Iwasaki T., et al. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 30 5 (2003) 1093-1096
29. Chen D.Y., Lan J.L., Lin F.J., and Hsieh T.Y. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. Arthritis Rheum 53 3 (2005) 320-327
30. Hoshino T., Ohta A., Nakao M., Ota T., Inokuchi T., Matsueda S., et al. TCR gamma delta + T cells in peripheral blood of patients with adult Still's disease. J Rheumatol 23 1 (1996) 124-129
31. Elkon K.B., Hughes G.R., Bywaters E.G., Ryan P.F., Inman R.D., Bowley N.B., et al. Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum 25 6 (1982) 647-654
32. Elezoglou A.V., Giamarelos-Bourboulis E., Katsilambros N., and Sfikakis P.P. Cutaneous vasculitis associated with mixed cryoglobulinemia in adult Still's disease. Clin Exp Rheumatol 21 3 (2003) 405-406
33. Kirino Y., Takeno M., Iwasaki M., Ueda A., Ohno S., Shirai A., et al. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther 7 3 (2005) R616-R624
34. Pascual V., Allantaz F., Arce E., Punaro M., and Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. [see comment]. J Exp Med 201 9 (2005) 1479-1486
35. Dinarello C.A. Interleukin-1beta. Crit Care Med 33 suppl 12 (2005) S460-S462
36. Petrilli V., Papin S., and Tschopp J. The inflammasome. Curr Biol 15 15 (2005) R581
37. Dinarello C.A. Blocking IL-1 in systemic inflammation. J Exp Med 201 9 (2005) 1355-1359
38. Arlet J.B., Leth D., Marinho A., Amoura Z., Wechsler B., Papo T., et al. Reactive haemophagocytic syndrome in adult onset Still's disease: report of 6 patients and review of the literature. Ann Rheum Dis (2006) ePub, Mar 15.
39. Grom A.A. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?. Curr Opin Rheumatol 15 5 (2003) 587-590
40. Amenomori M., Migita K., Miyashita T., Yoshida S., Ito M., Eguchi K., et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol 23 1 (2005) 100-102
41. Villanueva J., Lee S., Giannini E.H., Graham T.B., Passo M.H., Filipovich A., et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7 1 (2005) R30-R37
42. Grom A.A., Villanueva J., Lee S., Goldmuntz E.A., Passo M.H., and Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142 3 (2003) 292-296
43. Masson C., Le Loet X., Liote F., Renou P., Dubost J.J., Boissier M.C., et al. Adult Still's disease. Part II. Management, outcome, and prognostic factors. Rev Rhum Engl Ed 62 11 (1995) 758-765
44. Wouters J.M., and van de Putte L.B. Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61 235 (1986) 1055-1065
45. Cush J.J. Adult-onset Still's disease. Bull Rheum Dis 49 6 (2000) 1-4
46. Masson C., Le Loet X., Liote F., Dubost J.J., Boissier M.C., Perroux-Goumy L., et al. Comparative study of 6 types of criteria in adult Still's disease. J Rheumatol 23 3 (1996) 495-497
47. Reginato A.J., Schumacher Jr. H.R., Baker D.G., O'Connor C.R., and Ferreiros J. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17 1 (1987) 39-57
48. Koizumi R., Tsukada Y., Ideura H., Ueki K., Maezawa A., and Nojima Y. Treatment of adult Still's disease with dexamethasone, an alternative to prednisolone. Scand J Rheumatol 29 6 (2000) 396-398
49. Khraishi M., and Fam A.G. Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy. J Rheumatol 18 7 (1991) 1088-1090
50. Shojania K., Chalmers A., and Rangno K. Cyclosporin A in the treatment of adult Still's disease. J Rheumatol 22 7 (1995) 1391-1392
51. Cush J.J., Medsger Jr. T.A., Christy W.C., Herbert D.C., and Cooperstein L.A. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 30 2 (1987) 186-194
52. Larson E.B. Adult Still's disease. Evolution of a clinical syndrome and diagnosis, treatment, and follow-up of 17 patients. Medicine (Baltimore) 63 2 (1984) 82-91
53. Wouters J.M., van Rijswijk M.H., and van de Putte L.B. Adult onset Still's disease in the elderly: a report of two cases. J Rheumatol 12 4 (1985) 791-793
54. Fautrel B., Borget C., Rozenberg S., Meyer O., Le Loet X., Masson C., et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 26 2 (1999) 373-378
55. Aydintug A.O., D'Cruz D., Cervera R., Khamashta M.A., and Hughes G.R. Low dose methotrexate treatment in adult Still's disease. J Rheumatol 19 3 (1992) 431-435
56. Mahmud T., and Hughes G.R. Intravenous immunoglobulin in the treatment of refractory adult Still's disease. J Rheumatol 26 9 (1999) 2067-2068
57. Permal S., Wechsler B., Cabane J., Perrot S., and Blum B. Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Interne 16 (1995) 250-254
58. Vignes S., Wechsler B., Amoura Z., Papo T., Frances C., Huong D.L., et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 16 3 (1998) 295-298
59. Cefle A. Leflunomide and azathioprine combination in refractory adult-onset Still's disease. Ann Pharmacother 39 4 (2005) 764-767
60. Bennett A.N., Peterson P., Sangle S., Hangartner R., Abbs I.C., Hughes G.R., et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 43 6 (2004) 795-799
61. Benucci M., Li G.F., Del Rosso A., and Manfredi M. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report. Clin Exp Rheumatol 23 5 (2005) 733
62. Asherson R.A., and Pascoe L. Adult onset Still's disease: response to Enbrel. Ann Rheum Dis 61 9 (2002) 859-860 author reply 60.
63. Husni M.E., Maier A.L., Mease P.J., Overman S.S., Fraser P., Gravallese E.M., et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 46 5 (2002) 1171-1176
64. Serratrice J., Granel B., Disdier P., Weiller P.J., and Dussol B. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med 115 7 (2003) 589-590
65. Cavagna L., Caporali R., Epis O., Bobbio-Pallavicini F., and Montecucco C. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 19 3 (2001) 329-332
66. Huffstutter J., and Sienknecht C. Treatment of resistant adult Still's disease with Infliximab: a report of 2 cases. J Clin Rheumatol 10 4 (2004) 218-221
67. Bonilla Hernan M.G., Cobo Ibanez T., de Miguel Mendieta E., and Martin-Mola E. [Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases]. An Med Interna 21 1 (2004) 23-26
68. Caramaschi P., Biasi D., Carletto A., and Bambara L.M. A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol 20 1 (2002) 113
69. Dilhuydy M.S., Vatan R., Etienne G., Longy-Boursier M., and Mercie P. Prolonged efficacy of infliximab for refractory adult-onset Still's disease. Clin Exp Rheumatol 23 1 (2005) 121-122
70. Olivieri I., de Stefano G., Padula A., La Gala A., and de Stefano C. Infliximab in a case of early adult-onset Still's disease. Clin Rheumatol 22 4-5 (2003) 369-370
71. Dechant C., Schauenberg P., Antoni C.E., Kraetsch H.G., Kalden J.R., and Manger B. [Longterm outcome of TNF blockade in adult-onset Still's disease]. Dtsch Med Wochenschr 129 23 (2004) 1308-1312
72. Kokkinos A., Iliopoulos A., Greka P., Efthymiou A., Katsilambros N., and Sfikakis P.P. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23 1 (2004) 45-49
73. Fautrel B., Sibilia J., Mariette X., and Combe B. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64 2 (2005) 262-266
74. Quartier P., Taupin P., Bourdeaut F., Lemelle I., Pillet P., Bost M., et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48 4 (2003) 1093-1101
75. Horneff G., Schmeling H., Biedermann T., Foeldvari I., Ganser G., Girschick H.J., et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63 12 (2004) 1638-1644
76. Klausner JD, Freedman VH, Kaplan G. Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. Clin Immunol Immunopathol 81(3):219-23.
77. Weber D. Thalidomide and its derivatives: new promise for multiple myeloma. Cancer Control 10 5 (2003) 375-383
78. Lehman T.J., Schechter S.J., Sundel R.P., Oliveira S.K., Huttenlocher A., and Onel K.B. Thalidomide for severe systemic onset juvenile rheumatoid arthritis: a multicenter study. J Pediatr 145 6 (2004) 856-857
79. Meaux-Ruault N., Magy N., Gil H., and Dupond J.L. Efficacy of thalidomide in refractory adult Still's disease: a new case report. Clin Exp Rheumatol 21 2 (2003) 272
80. Stambe C., and Wicks I.P. TNFalpha and response of treatment-resistant adult-onset Still's disease to thalidomide. Lancet 352 9127 (1998) 544-545
81. Yokota S., Miyamae T., Imagawa T., Iwata N., Katakura S., Mori M., et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 52 3 (2005) 818-825
82. Iwamoto M., Nara H., Hirata D., Minota S., Nishimoto N., and Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheum 46 12 (2002) 3388-3389
83. Godinho F., Santos M.J., and Canas Da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 64 (2005) 647-648
84. Aelion J., and Odhav S. Prompt response to treatment with anakinra in adult onset Still's disease. Ann Rheum Dis 63 suppl (2004) 281
85. Haraoui B., Bourrelle D., and Kaminska E. Anakinra in the treatment of adult onset Still's disease. Ann Rheum Dis 63 suppl (2004) 293-294
86. Fitzgerald A.A., Leclercq S.A., Yan A., Homik J.E., and Dinarello C.A. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52 6 (2005) 1794-1803